A Clinical and Economic Comparison of Cell-Based Versus Recombinant Influenza Vaccines in Adults 18–64 Years in the United States

A Clinical and Economic Comparison of Cell-Based Versus Recombinant Influenza Vaccines in Adults 18–64 Years in the United States

Background: This analysis compares the cost-effectiveness of a cell-based influenza vaccine to a recombinant influenza vaccine, and each to no vaccination. The analysis is based on United States (US) commercial and societal perspectives. Methods: A Susceptible–Exposed–Infectious–Recovered (SEIR) tra...

Full description

Saved in:

Bibliographic Details
Main Authors:	Myron J. Levin, Neda Al Rawashdh, Liliane Mofor, Pablo Anaya, Richard M. Zur, Emily B. Kahn, Daniel Yu, Joaquin F. Mould-Quevedo
Format:	Article
Language:	English
Published:	MDPI AG 2024-10-01
Series:	Vaccines
Subjects:	cell-based influenza vaccine recombinant influenza vaccine cost-effectiveness United States
Online Access:	https://www.mdpi.com/2076-393X/12/11/1217
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Randomised immunogenicity trial comparing 2019-2020 recombinant and egg-based influenza vaccines among frequently vaccinated healthcare personnel in Israel
by: Ashley L. Fowlkes, et al.
Published: (2024-12-01)

Inactivated recombinant influenza vaccine: the promising direction for the next generation of influenza vaccine
by: Hua Shi, et al.
Published: (2024-12-01)

Modelling the population-level benefits and cost-effectiveness of cell-based quadrivalent influenza vaccine for children and adolescents aged 6 months to 17 years in the US
by: Stephen I. Pelton, et al.
Published: (2024-12-01)

A clinical and economic assessment of adjuvanted trivalent versus standard egg-derived quadrivalent influenza vaccines among older adults in the United States during the 2018-19 and 2019-20 influenza seasons
by: Myron J. Levin, et al.
Published: (2024-12-01)

Absenteeism and Productivity Loss Due to Influenza or Influenza-like Illness in Adults in Europe and North America
by: David Fisman, et al.
Published: (2024-12-01)

Protective Impact of Influenza Vaccination on Healthcare Workers
by: Yimei Tian, et al.
Published: (2024-10-01)

Cell-Cultured Influenza Vaccine Enhances IFN-γ+ T Cell and Memory T Cell Responses Following A/Victoria/2570/2019 IVR-215 (A/H1N1) Infection
by: Kyu-Ri Kang, et al.
Published: (2024-12-01)

Effectiveness of influenza vaccination in preventing confirmed influenza cases and hospitalizations in Northern Spain, 2023/24 season: A population-based test-negative case-control study
by: Iván Martínez-Baz, et al.
Published: (2025-02-01)

Attitudes, Beliefs, and Self-Reported Rates of Influenza and COVID-19 Vaccinations in the Canadian 2023–2024 National Influenza and Respiratory Viruses Survey
by: Samir Sinha, et al.
Published: (2024-10-01)

Evaluating Families’ Opinions of Routine Influenza Vaccination in Children Under 5 Years of Age in Spain
by: Sílvia Burgaya-Subirana, et al.
Published: (2025-01-01)

Is Avian influenza virus still threatening humans? Preventative measures and treatment
by: Jacek Fordymacki, et al.
Published: (2025-01-01)

Mapping and ranking outcomes for the evaluation of seasonal influenza vaccine efficacy and effectiveness: a delphi study
by: Chiara de Waure, et al.
Published: (2024-12-01)

Advantages of Broad-Spectrum Influenza mRNA Vaccines and Their Impact on Pulmonary Influenza
by: Ziqi Cheng, et al.
Published: (2024-12-01)

A Modified Novel Validated High-Throughput Hemagglutinin Inhibition Assay Using Recombinant Virus-like Particles and Human Red Blood Cells for the Objective Evaluation of Recombinant Hemagglutinin Nanoparticle Seasonal Influenza Vaccine
by: Timothy S. Vincent, et al.
Published: (2024-11-01)

Influenza burden averted with a cell-based quadrivalent seasonal influenza vaccine compared with egg-based quadrivalent seasonal influenza vaccine
by: Ian McGovern, et al.
Published: (2024-12-01)

Cross-protection against homo and heterologous influenza viruses via intranasal administration of an HA chimeric multiepitope nanoparticle vaccine
by: Yongqiang Zhao, et al.
Published: (2025-02-01)

Cost-effectiveness of cell-based influenza vaccine in France
by: Gaetan Gavazzi, et al.
Published: (2024-12-01)

Influenza knowledge and barriers to vaccination in immunosuppressed patients in the pediatric rheumatology clinic
by: Julia G. Harris, et al.
Published: (2024-12-01)

Factors Associated With Influenza Vaccination in a National Veteran Cohort
by: Alissa S. Chen, MD, et al.
Published: (2025-02-01)

IAPSM’s Position Paper on Influenza Vaccines for Adult Immunization in India
by: Nikita Sharma, et al.
Published: (2024-12-01)

Prescription of Antibiotics Among Patients Receiving Oseltamivir with an Influenza Related Diagnosis Over Three Influenza Seasons
by: Mine Durusu Tanriover, et al.
Published: (2024-12-01)

The Development of a Novel Broad-Spectrum Influenza Polypeptide Vaccine Based on Multi-Epitope Tandem Sequences
by: Song Zhao, et al.
Published: (2025-01-01)

Influencing factors for influenza vaccination among the elderly
by: LI Yiyao, LI Xiaoju, SHEN Xiaoying, ZHANG Xianqi, ZHAO Li, ZHANG Yuhan, WANG Xinmeng
Published: (2025-01-01)

Understanding barriers to influenza vaccination among parents is important to improve vaccine uptake among children
by: Stephanie A. Davey, et al.
Published: (2025-12-01)

Vaccine effectiveness against influenza-associated hospitalizations in adults with liver disease, 2015–2020: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN)
by: Po-Han Huang, et al.
Published: (2025-12-01)

Renal Transplant Hastalarında İnfluenza ve Pnömokok Aşı Farkındalığı
by: Zeynep Bıyık
Published: (2019-01-01)

The Impact of Obesity on Influenza Vaccine Immunogenicity and Antibody Transfer to the Infant During Pregnancy
by: Michelle Clarke, et al.
Published: (2024-11-01)

Are we serologically prepared against an avian influenza pandemic and could seasonal flu vaccines help us?
by: Iván Sanz-Muñoz, et al.
Published: (2025-02-01)

COVID-19 infection following influenza vaccine injection and its complications among nurses working in educational-medical hospitals of Ardabil in 2020
by: Ali Bakhtiari Kerigh, et al.
Published: (2023-05-01)

H1N1 influenza among hematological patients: monocentric influenza cases from 2011 to 2016.
by: Elisabetta Metafuni, et al.
Published: (2017-03-01)

Safety of quadrivalent recombinant influenza vaccine in pregnant persons and their infantsAJOG Global Reports at a Glance
by: Amber Hsiao, PhD, MPH, et al.
Published: (2024-11-01)

Influenza disease burden and the need for highly immunogenic vaccines in older adults: a narrative review
by: Joon Young Song
Published: (2024-07-01)

Time lapses between distribution of influenza vaccines to health authorities and their administration by General Practitioners (GPs) to older adults: a retrospective study over five influenza seasons in Italy
by: Francesco Lapi, et al.
Published: (2024-12-01)

Australian preferences for influenza vaccine attributes and cost: A discrete choice experiment
by: Simon Fifer, et al.
Published: (2025-12-01)

Influenza vaccination hesitancy and related factors among pregnant and breastfeeding women: A cross-sectional study
by: Dania Comparcini, et al.
Published: (2025-12-01)

Waning intra-season vaccine effectiveness against influenza A(H3N2) underlines the need for more durable protection
by: Alexander Domnich, et al.
Published: (2024-12-01)

Influenza Vaccination Rates, Perceptions, and Vaccine Hesitancy in K-12 Teachers and Staff
by: Kevin Cleveland, et al.
Published: (2025-02-01)

Factors Affecting Influenza and Pneumococcal Vaccination Rates in Hemodialysis Patients: A Multicenter Study
by: Selen T, et al.
Published: (2025-01-01)

A gram-positive enhancer matrix particles vaccine displaying swine influenza virus hemagglutinin protects mice against lethal H1N1 viral challenge
by: Yufei Zhang, et al.
Published: (2025-01-01)

Influenza vaccine effectiveness against medically-attended influenza infection in 2023/24 season in Hangzhou, China
by: Hao Lei, et al.
Published: (2025-12-01)